...

AI-Powered “Depression Thermometer” to Aid Interventional Psychiatry Network via Strategic Partnership with Emobot for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)

March 30, 2026

Via Get News

NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge

March 30, 2026

Via PRLog

Biogen Stock Pops After FDA Approves New High-Dose Spinraza For Spinal Muscular Atrophy ↗

March 30, 2026

Via Benzinga

From Shenzhen to the World: How Sunflower Dental Lab Became a Global Leading Dental Implant Service Powerhouse

March 30, 2026

Via AB Newswire

CCHR: Psychiatric Drugs Fuel Rising Death Toll: National Adverse Drug Event Awareness Day Confronts America's Medication Crisis

March 30, 2026

Via PRLog

New Book It’s Raining Fish by Gloria Joanne Kramer-Gordon, Ed.D. Explores Cultural Identity and Classroom Diversity

March 27, 2026

Via GlobePRwire

Sysco’s $29 Billion Bet: Foodservice Giant Swallows Jetro Restaurant Depot to Dominate Cash-and-Carry Market

March 30, 2026

Via MarketMinute

MoonLake Says Lead Drug Shows Durable Response, Eyes FDA Filing ↗

March 30, 2026

Via Benzinga

Industrial Intelligence: Stellantis’ High-Stakes AI Pivot with Palantir

March 30, 2026

Via Finterra

Altria's Oral Nicotine Pouch Product Is Going Nationwide. Is the Stock a Buy in 2026? ↗

March 30, 2026

Via The Motley Fool

Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762

March 30, 2026

Via Newsfile

CCHR: Time to End the Psychotropic Pill Epidemic – National Adverse Drug Event Awareness Day Exposes America’s Hidden Medication Crisis

March 30, 2026

Via Send2Press

Psilocybin-Assisted Therapy: A Modern Approach to Mental Health Innovation

March 30, 2026

Via BusinesNews Wire

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

March 28, 2026

Via TheNewswire.com

Kessler Topaz Meltzer & Check, LLP Filed a Securities Fraud Class Action Lawsuit Against uniQure N.V. (QURE); April 13, 2026, Lead Plaintiff Deadline

March 28, 2026

Via NewMediaWire

SLNO DEADLINE FOR LEADERSHIP is May 5, 2026 in a Securities Fraud Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) - Contact Kaplan Fox

March 28, 2026

Via TheNewswire.com

SLNO DEADLINE FOR LEADERSHIP is May 5, 2026 in a Securities Fraud Lawsuit Against Soleno Therapeutics, Inc. (NASDAQ: SLNO) - Contact Kaplan Fox

March 28, 2026

Via NewMediaWire

Deadline is April 21, 2026 to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox

March 28, 2026

Via NewMediaWire

Deadline is April 21, 2026 to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (NASDAQ: CORT) - Contact Kaplan Fox

March 28, 2026

Via TheNewswire.com

Australian Personal Alarm Company Cuts Elderly Care Costs with Subscription-Free Safety Device

March 27, 2026

Via AB Newswire

Why Corcept Therapeutics Zoomed Nearly 9% Higher This Week ↗

March 27, 2026

Via The Motley Fool

Eli Lilly Shares Slip Despite Positive Eczema Trial Results: Why the Market Reacted Coolly

March 27, 2026

Via MarketMinute

AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results

March 27, 2026

Via MarketMinute

Professional OEM Manufacturing of Global Coffee Mugs

March 27, 2026

Via AB Newswire

Google Just Unveiled TurboQuant: Should You Sell Sandisk Stock Now?

March 27, 2026

Via Barchart.com

Bridging the Gap in NSCLC Therapy: The Rise of Antibody-Drug Conjugates

March 27, 2026

Via AB Newswire

DBV Technologies Sets Stage For 'Swift' Success As Breakthrough Peanut Patch Nears FDA Submission ↗

March 27, 2026

Via Benzinga

CORCEPT THERAPEUTICS DEADLINE FOR LEADERSHIP is April 21, 2026 in a Securities Fraud Lawsuit - Investors Encouraged to Contact Kaplan Fox

March 27, 2026

Via NewMediaWire

CORCEPT THERAPEUTICS DEADLINE FOR LEADERSHIP is April 21, 2026 in a Securities Fraud Lawsuit - Investors Encouraged to Contact Kaplan Fox

March 27, 2026

Via TheNewswire.com

Kaplan Fox Reminds Investors of Soleno Therapeutics, Inc. (SLNO) to a Class Action Deadline on May 5, 2026

March 27, 2026

Via TheNewswire.com

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.